top of page

China: Updates on Revised Medical Device Regulations

  • Writer: ARQon
    ARQon
  • Sep 20, 2021
  • 2 min read

Updated: Sep 21, 2021

In March 2021, China has announced revision of Regulations on the Supervision and Administration of Medical Devices (State Council Order No. 739, taking effect starting from 1 June 2021. The National Medical Products Administration (NMPA) and the Center for Medical Device Evaluation (CMDE) have published additional statements and documentation supporting the regulation change since it was announced.


Announcement on the background and objectives of Order 739 by NMPA


The NMPA delivered the following announcement in the spring, detailing the background of Order 739:


These announcements provide more detailed information on the four main points of the revised regulations:

· Execution of changes influencing the medical device review and approval system

· Optimize archiving procedures, prioritize innovative medical devices and reduce the burden on the company

· Strengthen the life cycle process of medical devices and improve the efficiency of supervision

· Increase penalties and costs for violations


NMPA provides detailed information on the implementation of Order 739 and its direct impact on companies


In late May, the NMPA has make an announcement detailing the implementation of Order No. 739, as the development and revision of relevant regulations and guidelines is in progress.



Sources:


Contact us at info@arqon.com for more info


 
 
 

Comments


bottom of page